
First Longevity is a leading provider of news and insights in the rapidly expanding longevity market. They focus on anti-aging, biotechnology, research, investment, supplements, and rejuvenation therapies. Their platform offers a comprehensive view of the longevity sector, covering various categories such as AI, nanotechnology, drugs, agritech, and investment, while monetizing content through display advertisements. With a commitment to empowering individuals and organizations, First Longevity aims to redefine health and wellness in the context of longevity.

First Longevity is a leading provider of news and insights in the rapidly expanding longevity market. They focus on anti-aging, biotechnology, research, investment, supplements, and rejuvenation therapies. Their platform offers a comprehensive view of the longevity sector, covering various categories such as AI, nanotechnology, drugs, agritech, and investment, while monetizing content through display advertisements. With a commitment to empowering individuals and organizations, First Longevity aims to redefine health and wellness in the context of longevity.
Sector: Longevity news & market intelligence
Founded: Dec 2019
Founder / CEO: Phil Newman
Funding: Seed round Aug 2020; amount undisclosed; investors include LongeVC and Longevitytech.fund
Business model: Monetizes content via display advertising
Longevity market (anti-aging, biotechnology, research, investment, supplements, rejuvenation therapies).
2019
News/media publishing; market intelligence (longevity sector)
Reported investors include Longevitytech.fund and LongeVC; amount undisclosed.
“Seed investors reported include LongeVC and Longevitytech.fund.”